Lyrica Gets Expanded Approval in Japan for Peripheral Neuropathic Pain

Oct 28 (Reuters) - Japanese health regulators approved Pfizer Inc's (PFE.N) Lyrica to treat a type of nerve pain called peripheral neuropathic pain, Pfizer said on Thursday.